Particle.news
Download on the App Store

Trump, HHS Respond After Scott Adams Seeks Help for Delayed Cancer Therapy

White House officials replied within hours to Adams' report of delays scheduling an approved Pluvicto infusion.

Overview

  • Adams says Kaiser Permanente in Northern California approved his Pluvicto treatment but has not scheduled the IV infusion, adding that he is declining fast.
  • He wrote that he would ask President Trump to intervene to get the infusion scheduled as soon as Monday.
  • HHS Secretary Robert F. Kennedy Jr. publicly asked how to reach Adams, and President Trump posted that he was "on it."
  • White House deputy chief Dan Scavino said officials, including Dr. Mehmet Oz, are tracking the case, and a Kaiser‑affiliated physician said medical directors would contact Adams today.
  • Pluvicto is an FDA‑approved radioligand therapy for PSMA‑positive metastatic castration‑resistant prostate cancer, and there is no confirmation that Adams' infusion has been scheduled or administered.